期刊文献+

医院开展静脉药物配置中心工作的探讨 被引量:5

Discussion that the Hospital Launches Vein Medicines and Disposes the Central Task Old to Make a Leap Forward
下载PDF
导出
摘要  目的探讨医院开展静脉药物配置中心(Pharmacy Intravenous Admixture Services PIVAS)工作的作用和意义。方法依据药物特性设计而且符合GMP规范,建立静脉药物配置中心、制定医院全封闭输液配置中心药物领用流程、配药信息传递流程、配药工作流程及相关的管理规程。结果与结论开展静脉药物配置中心,保证溶液的无菌性;防止微粒污染;推动临床药学发展;将给药错误减少至最低;确保相溶性和稳定性;减少药物浪费和减低成本;确保职业暴露防护。 Objective Probe into the hospital and launches vein medicines and disposes the functionand meaning of the work of the centre (Pharmacy Intravenous Admixture Services PIVAS). Methods Designsand accords with GMP norm according to the medicine characteristic, set up vein medicines and disposethe centre, make hospital totally closed infusion dispose centre medicine receive procedure, make up aprescription information transmission procedure, make up a prescription workflow and relevant rules ofmanagement. Result and conclusion Launch vein medicines and dispose the centre, guarantee theasepsis of the solution; Prevent the particle from polluting; Promote the development of clinicalpharmacy; Give medicine mistake to reduce to lowest; Guarantee dissolving and stability; Reducing themedicine wasteds and lowers the cost; Guarantee that the job is exposed and protected.
出处 《国际医药卫生导报》 2004年第18期132-134,共3页 International Medicine and Health Guidance News
关键词 静脉药物配置中心 无菌性 质量 合理用药 The vein medicine disposes the centre Asepsis Quality Using medicine rationally
  • 相关文献

参考文献1

二级参考文献11

  • 1宋作斌.静脉药物配置中心简介[J].天津护理,2001,9(4):213-214. 被引量:2
  • 2Crawford SY, NaiducciWA, Augustine SC. National survey of quality assurance activities for pharmacy - prepared sterile products in hospitals [J]. Am J Hosp Pharm, 1991, 48( 11 ): 2398 - 413.
  • 3Vogel DP, Eck TA, Witte K. W. Calculation of product waste in Ⅳ Admixture program [J]. AJHP, 1986, 43:952 - 953.
  • 4Paoletti RD, Cerey EW. Reducing costs through centraliazation and standardization of an i. v. admixture program [J]. Am J HealthSyst Pharm, 2000, 57 (12) : 1147 - 1149.
  • 5Hitt CM, Nightingale CH. Cost comparison of single daily i. v. doses of ceftriaxone versus continuous infusion of cefotaxime[J]. Am J Syst Pharm, 1997, 54( 14): 1614- 1618.
  • 6Armour DJ, Caims C J, Costello I, et al. The economics of a pharmacy - based central intravenous additive service for paediatric patients[J]. Pharmacoeconomics, 1996, 10(4): 386- 394.
  • 7Hotchkies L, Grima DT, Hedayati S. The total process cost of parenteral antibiotic therapy: beyond drug acquisition cost [J], Clin Ther, 1996, 18(4): 716 -725.
  • 8Uchida KM, Iteen SA, Wong NT. Identifying costs of intravenous solution wastage [J]. Pharmacoeconomics, 1994, 6(3): 240- 248.
  • 9Milkovich G. Int J Antimicrob Agents [J]. The role of the hospital pharmacist in cost control and antibiotic policy, 2000, 16(3): 291 -294.
  • 10Plumridge RJ, Maher M. Justification of a pharmacy intravenous admixture service in an Australian hospital [J]. Am J Hosp Pharm,.1993, 50(3): 463 -466.

共引文献23

同被引文献18

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部